Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Justine L. Smith
Institutions:
Churchill Hospital,
Cancer Research UK,
John Radcliffe Hospital,
University of Warwick,
University of Oxford,
University of Birmingham
show all 6
Observed institutions:
Churchill Hospital,
Cancer Research UK,
John Radcliffe Hospital,
University of Warwick,
University of Oxford,
University of Birmingham
show all 6
OpenAlex ID:
A5111869956
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
2007
·
David J. Kerr
, Janet A. Dunn
, et al.
·
New England Journal of Medicine
·
146
PDF
Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
2010
·
Rachel S. Midgley
, Christopher C. McConkey
, et al.
·
Journal of Clinical Oncology
·
109
PDF
A Trial of Adjuvant Therapy in Colorectal Cancer: The VICTOR Trial
2003
·
Stuart Pendlebury
, Francesca Duchesne
, et al.
·
Clinical Colorectal Cancer
·
19
VICTOR : a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
2026
·
Rachel S. J. Midgley
, Christopher C. McConkey
, et al.
·
University of Warwick
Show more works
View as search
Works count:
5
Citation count:
274
H-index:
3
I10-index:
3
Year
Topic
Type